Products / Oncology and Hematology
Solid Tumors
The molecular-level analysis of solid tumors forms the basis for personalized oncology applications.
Next-Generation Sequencing (NGS) plays a significant role in diagnosis, prognostic evaluation, and targeted treatment selection by detecting genetic variations in these tumors with high sensitivity.
NGS-based panels provide multidimensional data at both the DNA and RNA levels, enabling the evaluation of various molecular biomarkers such as fusions, mutations, and expression levels.
Amplicon-Based Panels
Accurate and comprehensive detection of genetic variants in molecular oncology is critical for diagnosis and treatment decisions.
With Next Generation Sequencing (NGS), SNVs, Indels, CNVs, and fusions can be analyzed in a single panel. Library preparation methods appropriate for the sample type and analysis purpose directly affect panel performance.
Hybridization-Based Panels
The detection of somatic variants in solid tumors with high sensitivity and broad coverage is of great importance for identifying biomarkers that will guide treatment.
With hybrid capture-based Next Generation Sequencing (NGS) methods, a wide variety of variant types such as SNV, Indel, CNV, fusions, and TMB can be characterized in detail in a single analysis.
Expert Insights into NGS: Pathology
Associate Professor Dr. İbrahim Kulaç discusses how next-generation sequencing is transforming the field of pathology.